Cargando…
siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells
Activatable cell-penetrating peptides (aCPPs) allow non-viral, low cytotoxic and selective delivery of compounds into target cells for cancer therapy. In tumour cells, up-regulation of human telomerase reverse transcriptase (hTERT) frequently occurs and is being considered as a target in cancer diag...
Autores principales: | Li, Hua, He, Jiwen, Yi, Huimin, Xiang, Guoan, Chen, Kaiyun, Fu, Binsheng, Yang, Yang, Chen, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370094/ https://www.ncbi.nlm.nih.gov/pubmed/25671640 http://dx.doi.org/10.1042/BSR20140145 |
Ejemplares similares
-
Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
por: Xiang, Bai, et al.
Publicado: (2017) -
Versatility of cell-penetrating peptides for intracellular delivery of siRNA
por: Singh, Tejinder, et al.
Publicado: (2018) -
Activatable cell-penetrating peptides: 15 years of research
por: de Jong, Heleen, et al.
Publicado: (2020) -
The intrabody targeting of hTERT attenuates the immortality of cancer cells
por: Zhu, Xiangying, et al.
Publicado: (2009) -
Peptide-Ligand Binding Modeling of siRNA with Cell-Penetrating Peptides
por: García-Sosa, Alfonso T., et al.
Publicado: (2014)